Interpace Biosciences, Inc.
IDXG
Revenue
12.04M
▲1.77M▲17.22%
3 Months ChangeAssets
12.97M
▲830.00k▲6.84%
3 Months ChangeLiabilities
25.46M
▼-1.29M▼-4.80%
3 Months ChangeFree Cash Flow
-86.00k
▼-1.15M▼-108.05%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-15
Form 8-K
ID: 0001493152-24-041144
2024-08-08
Form 10-Q
ID: 0001493152-24-030772
2024-08-02
Form 8-K
ID: 0001493152-24-030102
2024-05-09
Form 8-K
ID: 0001493152-24-018465
2024-05-09
Form 10-Q
ID: 0001493152-24-018432
2024-03-13
Form 8-K
ID: 0001493152-24-009737
2023-12-12
Form 8-K
ID: 0001493152-23-044550
2023-11-16
Form 8-K
ID: 0001493152-23-041662
2023-11-08
Form 8-K
ID: 0001493152-23-039945
2023-11-08
Form 10-Q
ID: 0001493152-23-039909